Mergers & Acquisitions

Kelso & Company Acquires Valenz® Health

6078 Valenz Health NT

M&A Engagement Overview

Industry Group: Healthcare & Life Sciences
Area of Focus: Payers and Payer Services

Harris Williams advised Kelso & Company on its acquisition of Vālenz® Health, a portfolio company of Great Point Partners. Vālenz® is the operator of a single source, end-to-end analytics platform designed for medical cost reduction and claims flow management.

Based in Phoenix, Arizona, Vālenz® simplifies the complexities of self-insurance for employers through a steadfast commitment to data transparency and decision enablement powered by its Healthcare Ecosystem Optimization Platform. By leveraging data transparency and delivering an omnichannel approach across the healthcare journey, Vālenz® improves cost, quality, and outcomes for employers and their health plan members – engaging early and often for smarter, better, faster healthcare.

We are thrilled to have represented Kelso & Company on its purchase of Valenz® Health. Cost containment continues to be a focus area for employers who look to take more control over medical benefits design, claims repricing, and care navigation. Investors have recognized this, resulting in increased capital allocation into this high-growth and recession-resistant sector.

Vālenz® Health has assembled a compelling suite of cost containment capabilities, enabling them to sell an integrated offering to customers. This integrated offering is differentiated in the cost containment space, particularly in the context of serving small- and medium-sized enterprises that purchase through independent third-party administrators.

Healthcare cost inflation remains high and intractable, driving employers to pursue self-insurance and seek cost containment solutions. Companies that serve small and medium enterprises and payors, enable self-insurance, and provide tangible cost savings to their customers are positioned to grow significantly in the coming years.

Contact the Harris Williams Healthcare & Life Sciences Group to learn more about this transaction.

Harris Williams is a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality. We approach every engagement with boundless collaboration, pooling expertise and relationships across industries and geographies. For over 30 years, our clients have trusted us to think strategically, execute precisely, and deliver superior outcomes to help them grow.


Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 13th floor, One Angel Court, London EC2R 7HJ, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorised and regulated by the Financial Conduct Authority, number 5408952. Harris Williams Private Capital Advisory Ltd. is an Appointed Representative of Sturgeon Ventures, LLP, which is authorised and regulated by the Financial Conduct Authority number 452811. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is 16th Floor, Marienturm, Taunusanlage 9-10 60329, Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Director: Paul Poggi, VAT No. DE321666994. Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.